Skip to main content
. 2023 Jul 27;6(7):e2326230. doi: 10.1001/jamanetworkopen.2023.26230

Figure 2. Therapy Among Tested and Untested Patients by Quintile of Estimated Risk of Albuminuria (N = 149 554).

Figure 2.

ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; SGLT2i, sodium-glucose cotransporter 2 inhibitor.

aQuintile with a statistically significant difference between tested and untested groups. All comparisons of tested vs untested were significant to P < .001 except for the following: blood pressure less than 130/80 mm Hg for quintile 2 (P = .01), blood pressure less than 130/80 mm Hg for quintile 5 (P = .75), blood pressure less than 140/90 mm Hg for quintile 1 (P = .44), and blood pressure less than 140/90 mm Hg for quintile 2 (P = .02).